ClinVar

Description

p.Ser3Phe (TCC>TTC): c.8 C>T in exon 1 of the CACNB4 gene (NM_000726.2). The S3F variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The S3F variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved across species in the N-terminal region of the CACNB4 protein. Additionally, to date only a small number of substitutions in CACNB4 have been published in association with epilepsy, and no disease-associated mutations have been reported in the N-terminal region of the protein (Excayg et al., 2000; Ohmori et al., 2008). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in INFANT-EPI panel(s).